Related Experiment Video
Updated: Dec 26, 2025

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
Published on: May 17, 2016
An MXD1-derived repressor peptide identifies noncoding mediators of MYC-driven cell proliferation
Philipp Raffeiner1, Jonathan R Hart1, Daniel García-Caballero1
1Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.
Abstract:
MYC controls the transcription of large numbers of long noncoding RNAs (lncRNAs). Since MYC is a ubiquitous oncoprotein, some of these lncRNAs probably play a significant role in cancer. We applied CRISPR interference (CRISPRi) to the identification of MYC-regulated lncRNAs that are required for MYC-driven cell proliferation in the P493-6 and RAMOS human lymphoid cell lines. We identified 320 noncoding loci that play positive roles in cell growth. Transcriptional repression of any one of these lncRNAs reduces the proliferative capacity of the cells. Selected hits were validated by RT-qPCR and in CRISPRi competition assays with individual GFP-expressing sgRNA constructs. We also showed binding of MYC to the promoter of two candidate genes by chromatin immunoprecipitation. In the course of our studies, we discovered that the repressor domain SID (SIN3-interacting domain) derived from the MXD1 protein is highly effective in P493-6 and RAMOS cells in terms of the number of guides depleted in library screening and the extent of the induced transcriptional repression. In the cell lines used, SID is superior to the KRAB repressor domain, which serves routinely as a transcriptional repressor domain in CRISPRi. The SID transcriptional repressor domain is effective as a fusion to the MS2 aptamer binding protein MCP, allowing the construction of a doxycycline-regulatable CRISPRi system that allows controlled repression of targeted genes and will facilitate the functional analysis of growth-promoting lncRNAs.
Insights
Researchers identified 320 long noncoding RNAs (lncRNAs) crucial for MYC-driven cell proliferation using CRISPR interference. Repressing these MYC-regulated lncRNAs significantly reduces cancer cell growth, highlighting their oncogenic role.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The MYC oncoprotein regulates numerous long noncoding RNAs (lncRNAs), some of which are implicated in cancer development.
- Understanding the functional role of MYC-regulated lncRNAs is crucial for identifying novel cancer therapeutic targets.
Purpose of the Study:
- To identify MYC-regulated lncRNAs essential for cell proliferation in human lymphoid cancer cell lines.
- To evaluate the efficacy of the SIN3-interacting domain (SID) repressor in CRISPR interference (CRISPRi) screening.
Main Methods:
- CRISPR interference (CRISPRi) screening was employed in P493-6 and RAMOS cells to identify growth-promoting lncRNAs.
- Quantitative real-time PCR (RT-qPCR), CRISPRi competition assays, and chromatin immunoprecipitation (ChIP) were used for validation.
- The effectiveness of the SID repressor domain was compared against the KRAB repressor domain in CRISPRi.
Main Results:
- 320 noncoding loci were identified as positively regulating cell growth; repression of these lncRNAs decreased cell proliferation.
- MYC binding to the promoters of two candidate genes was confirmed via ChIP.
- The SID repressor domain demonstrated superior efficiency in transcriptional repression and guide depletion compared to KRAB in the tested cell lines.
Conclusions:
- MYC-driven cell proliferation is dependent on a specific set of lncRNAs.
- The SID repressor domain offers an effective tool for doxycycline-inducible CRISPRi, facilitating the functional study of growth-promoting lncRNAs.
- These findings provide a foundation for targeting MYC-regulated lncRNAs in cancer therapy.
Related Concept Videos
Abnormal Proliferation
Master Transcription Regulators
Induced Pluripotent Stem Cells
Somatic...
Negative Regulator Molecules
Co-activators and Co-repressors
RNA Polymerase II Accessory Proteins

